Ran Avnat

Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.

NeurOptics, Inc. provides neurological patient care services. It offers npi-100 pupillometer, an hand-held and cordless device that removes subjectivity in the measurement of pupil size and the pupillary light reflex. The company was founded by Kamran Siminou and is headquartered in Irvine, CA.

X-Cell Medical, Inc. develops drugs for cardiovascular clinical applications. It focuses on delivery of drugs with safety and efficacy profiles for cardiovascular indications including restenosis, myocardial infarction and vulnerable plaque. The company was founded in 2002 and is headquartered in Monmouth Junction, NJ.

Evogen is a global biological detection system company, and is the leading developer and manufacturer of High Definition PCR™ (HD PCR) molecular diagnostics systems, meeting the needs of a diverse range of markets including biodefense, clinical, research, animal health, agbio, food and water safety, indoor air quality, environmental monitoring and forensics. Through its core expertise and patented technologies in the collection, concentration, preparation and detection of clinical and environmental biological samples, the company have developed product offerings that range from stand-alone modules and assay kits through to fully integrated units for dedicated diagnostic tasks. The company are developing both semi- and fully-automated rapid HD PCR diagnostic systems and Automated Sample Preparation (ASP) technology for sample preparation.

Youdim Pharmaceuticals Ltd (Youdim Pharmaceuticals) is a venture capital subsidiary of XT Investments Ltd founded in 1997. The firm is headquartered in Yokneam, Israel.

Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund.

Outcome Capital LLC is a life sciences and healthcare advisory and investment banking firm that specializes in providing innovative companies with a value-added, market-aligned approach to mergers & acquisitions, partnering, and corporate finance. The firm was founded by Jonathan R. Wallace and is based in Boston, MA, with subsidiaries in the United States. The firm's multi-disciplinary team of industry experts draws from their broad relationships and a wide range of scientific, operational, strategic, and transactional expertise across the value chain to assist management teams and their boards in navigating both financial and corporate markets and implementing the best path for success.

XableCath, Inc. manufactures catheters for treatment of vascular diseases. The company was founded by Johannes B. Dahm and Lisa Jordan Dunlea in 2014 and is headquartered in Salt Lake City, UT.

ELT Sight, Inc. engages in the provision of healthcare services. It focuses on micro-invasive glaucoma surgery. The company is headquartered in Los Angeles, CA.

Famous NYC, Inc. is the company behind Famer, a sports coaching and mentorship mobile platform. The company is based in New York, NY, and the CEO of the company is Jonathan Leitersdorf. Famer enables team and personal training programs with interactive feedback between athletes and their coaches/club. It is a community for a sports club/organization, coach or trainer to host and distribute a library of custom training content. Famer provides deeper engagement between club, coaches, parents, and athletes resulting in greater retention. The platform is interactive where kids can send in video and also choose specific curated video. The coaches review each submitted segment and provide real-time instruction. Famer supports the youth sports industry by providing their platform to sports clubs/organizations to load up their own private communities and content to continue the training and communication with their athletes.

Caliber Therapeutics, Inc. is a holding company, which engages in the development of products for atherosclerotic diseases. It offers targeted angioplasty drug delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices. The company was founded on August 3, 2009 and is headquartered in New Hope, PA.